<DOC>
	<DOCNO>NCT03065530</DOCNO>
	<brief_summary>Nervous , anxiety , fear psychological reaction always appear parturients cesarean section . This study intend investigate effectiveness safety dexmedetomidine combine butorphanol tartrate postoperative analgesia breastfeed caesarean section .</brief_summary>
	<brief_title>Intravenous Dexmedetomidine Cesarean Section</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Butorphanol</mesh_term>
	<criteria>1 . Parturients undergo elective caesarean delivery epidural anaesthesia 2 . ASA I II parturients age 1842 year , singleton gestation . 3 . Parturients verbal write mandarin 4 . Parturients want use PCA intravenous analgesia use pump correctly 5. write informed consent . Exclusion Criteria 1 . Multiple gestation . 2 . A history allergy dexmedetomidine study drug 3 . Cardiovascular disease ( basic HR &lt; 50bpm SBP &lt; 100mmHg ) 4 . Opioid drug abuse . 5 . BMI 35 kg/m2 6 . Conditions preclude spinal anesthesia . 7 . Preeclampsia epilepsy . 8 . A history neuromuscular disease . 9 . Epidural anaesthesia unsuccessful .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Butorphanol tartrate</keyword>
	<keyword>Analgesia</keyword>
	<keyword>Breastfeeding</keyword>
	<keyword>Relative infant dose</keyword>
</DOC>